Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival
Sign Up to like & getrecommendations! Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-12584-0
Abstract: Immunotherapeutic strategies for glioblastoma, the most frequent malignant primary brain tumor, aim to improve its disastrous consequences. On top of the standard treatment, one strategy uses T cell activation by autologous dendritic cells (DC) ex… read more here.
Keywords: tumor; glioblastoma; tumor lysate; immunogenic autologous ... See more keywords